Open access
Open access
Powered by Google Translator Translator

Global & Public Health (all articles)

NICE COVID-19 Rapid Guideline: Dialysis Service Delivery

23 Mar, 2020 | 01:30h | UTC

COVID-19 rapid guideline: dialysis service delivery – National Institute for Health and Care Excellence (free)

See also: COVID-19: Updates for Nephrologists (free resources)

 


CDC Guidance: Preparing Long-term Care Facilities and Nursing Homes for COVID-19

24 Mar, 2020 | 11:28h | UTC

Preparing for COVID-19: Long-term Care Facilities, Nursing Homes – Centers for Disease Control and Prevention

Related Guideline: Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF)

Related Article: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report

Related Perspective: The Coronavirus’s Rampage Through a Suburban Nursing – The New York Times

 


CEBM Estimates Infection Rate Fatality (IFR) of COVID-19 at 0,20%

23 Mar, 2020 | 01:16h | UTC

Global Covid-19 Case Fatality Rates – Centre for Evidence-Based Medicine, University of Oxford (free)

 


[Preprint] Randomized Trial: Favipiravir vs. Arbidol for COVID-19

23 Mar, 2020 | 01:18h | UTC

Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial – medRxiv

 


Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19

23 Mar, 2020 | 01:34h | UTC

Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19 – World Health Organization (PDF)

Related Study: COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 – CDC Morbidity and Mortality Weekly Report (free)

“Introduction of COVID-19 into a long-term residential care facility in Washington resulted in cases among 81 residents, 34 staff members, and 14 visitors; 23 persons died” (from CDC)

 


IDSA Statement: COVID-19 Prioritization of Diagnostic Testing

20 Mar, 2020 | 11:01h | UTC

COVID-19 Prioritization of Diagnostic Testing – Infectious Diseases Society of America (free PDF)

Summary: IDSA Statement On COVID-19 Testing Recommendations – Infectious Diseases Society of America (free)

 


Editorial by John P.A. Ioannidis: COVID-19: The Harms of Exaggerated Information and Non‐evidence‐based Measures

23 Mar, 2020 | 01:08h | UTC

Coronavirus disease 2019: the harms of exaggerated information and non‐evidence‐based measures – European Journal of Clinical Investigation (free PDF)

Related Opinion Piece: A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data – STAT (free)

Rebuttal 1: We know enough now to act decisively against Covid-19. Social distancing is a good place to start – STAT (free)

Rebuttal 2: A Rebuttal to “A Fiasco in the Making?” – Hilda Bastian (Free)

 


New Preliminary Studies with Hydroxychloroquine:

20 Mar, 2020 | 10:57h | UTC

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial – International Journal of Antimicrobial Agents (free PDF)

This was an open-label study with only 42 patients without patient-relevant endpoints. The 6 patients that received Hydroxychloroquine + Azithromycin achieved more efficient virus elimination than control patients.

New in Vitro Study: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro – Cell Discovery (free)

Related Articles: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – Clinical Infectious Diseases (free PDF) AND New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? – International Journal of Antimicrobial Agents (free) AND A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 – Journal of Critical Care (free) AND Of chloroquine and COVID-19 – Antiviral Research (free)

 


Meta-Analysis: The Risk of Tuberculosis in Children After Close Exposure

23 Mar, 2020 | 00:52h | UTC

The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis – The Lancet (free)

Commentary: Incidence of Tuberculosis High in Children Exposed to the Disease – Drugs.com (free)

 


CDC Guideline: Strategies for Optimizing the Supply of Facemasks

20 Mar, 2020 | 11:03h | UTC

Strategies for Optimizing the Supply of Facemasks – Centers for Disease Control and Prevention (free)

 


Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

20 Mar, 2020 | 11:05h | UTC

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic – Journal of the American College of Cardiology (free)

Commentary: CVD in the Setting of COVID-19: Considerations to Prepare Patients, Providers, Health Systems – American College of Cardiology (free)

 


Video: Coronavirus Update with Anthony Fauci, MD

19 Mar, 2020 | 11:04h | UTC

Coronavirus Update with Anthony Fauci, MD – March 18, 2020 – JAMA (free)

 


Study: SARS-CoV-2 Infection in Children

19 Mar, 2020 | 10:59h | UTC

SARS-CoV-2 Infection in Children – New England Journal of Medicine (free)

Related Articles: Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China – Peditrics (free) Detection of Covid-19 in Children in Early January 2020 in Wuhan, China – New England Journal of Medicine (free) AND Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children – The Pediatric Infectious Diseases Journal (free PDF) AND Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding – Nature Medicine (free)

 


Randomized Trial: No Benefit from Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

19 Mar, 2020 | 11:01h | UTC

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 – New England Journal of Medicine (free)

Editorial: Covid-19 — The Search for Effective Therapy (free)

See also: Interview with Dr. Eric Rubin and Dr. Lindsey Baden on new research on possible treatments for Covid-19 – New England Journal of Medicine (free)

 


Podcast: New Research on Possible Treatments for Covid-19

19 Mar, 2020 | 10:57h | UTC

Interview with Dr. Eric Rubin and Dr. Lindsey Baden on new research on possible treatments for Covid-19 – New England Journal of Medicine (free)

 


Report: Impact of Non-pharmaceutical Interventions to Reduce COVID19 Mortality and Healthcare Demand

18 Mar, 2020 | 09:53h | UTC

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand – Imperial College London (free PDF)

Summary: Report 9 – Imperial College London (free)

Commentaries: US, UK coronavirus strategies shifted following UK epidemiologists’ ominous report – CNN (free) AND New Analysis Suggests Months Of Social Distancing May Be Needed To Stop Virus – NPR (free)

“…in an unmitigated epidemic, we would predict approximately 510,000 deaths in GB and 2.2 million in the US, not accounting for the potential negative effects of health systems being overwhelmed on mortality.”

 


Study: Aerosol and Surface Stability of SARS-CoV-2

18 Mar, 2020 | 09:50h | UTC

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 – New England Journal of Medicine (free)

Commentaries: New coronavirus stable for hours on surfaces – NIH News Releases (free) AND How Long Will Coronavirus Live on Surfaces or in the Air Around You? – The New York Times (10 articles per month are free) AND New coronavirus can persist in air for hours and on surfaces for days: study – Reuters (free)

 


Randomized, Phase 2 Trial: Safety and Immunogenicity of a Tetravalent Dengue Vaccine in Children Aged 2–17 Years

18 Mar, 2020 | 09:47h | UTC

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial – The Lancet (link to abstract – $ for full-text)

 


[Abstract Only] Study: Consequences of Measles Undervaccination

18 Mar, 2020 | 09:49h | UTC

Consequences of Undervaccination – Measles Outbreak, New York City, 2018-2019 – New England Journal of Medicine (link to abstract – $ for full-text)

 


Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

17 Mar, 2020 | 08:45h | UTC

Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China – Pediatrics (free PDF)

Commentary: Children with COVID-19 Impacted Less Severely Than Adults: Study – American Academy of Pediatrics (free)

 


‘A Ticking Time Bomb’: Scientists Worry About Coronavirus Spread in Africa

17 Mar, 2020 | 08:48h | UTC

‘A ticking time bomb’: Scientists worry about coronavirus spread in Africa – Science (free)

Related: Managing COVID-19 in Low- and Middle-Income Countries – JAMA (free) AND Inside the Efforts to Prepare African Countries for COVID-19 – TIME (free) AND Looming threat of COVID-19 infection in Africa: act collectively, and fast – The Lancet (free) AND Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? – lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future – International Journal of Infectious Diseases (free PDF)

 


COVID-19: Undocumented Infections are the Infection Source for 79% of Documented Cases

17 Mar, 2020 | 08:51h | UTC

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) – Science (free)

Commentaries: 80% of COVID-19 spreads from people who don’t know they are sick – UPI (free) AND Coronavirus Is Hiding in Plain Sight – The New York Times (10 articles per month are free)

Related: COVID-19: Who Is Infectious? – Forbes (free) AND Infected people without symptoms might be driving the spread of coronavirus more than we realized – CNN (free)

 


Interim Guidance: Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected

16 Mar, 2020 | 08:01h | UTC

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected – World Health Organization (free PDF)

Related: Severe SARS-CoV-2 Infections: Practical Considerations and Management Strategy for Intensivists (free studies and reviews)

 

Related Commentary on Twitter

 


Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response

16 Mar, 2020 | 07:55h | UTC

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response – JAMA (free)

Related Video: Coronavirus in Italy – Report From The Front Lines – JAMA (free)

 


Study: Characteristics of Pediatric SARS-CoV-2 Infection and Potential Evidence for Persistent Fecal Viral Shedding

16 Mar, 2020 | 07:50h | UTC

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding – Nature Medicine (free)

Commentaries: How Does The Coronavirus Affect Kids? What We Know So Far About COVID-19 In Children – Forbes (free) AND Coronavirus study finds children with COVID-19 show milder symptom pattern – Reuters (free)

“Children infected with the #COVID19 outbreak coronavirus, SARS-CoV-2, show mild symptoms but prolonged shedding of viral RNA in feces, suggesting that the fecal–oral route might play a role in virus transmission #CORONAVIRUS” (via @NatureMedicine see Tweet)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.